Insertable heart monitor finds elusive atrial fibrillation after unexplained stroke

February 17, 2014

A small cardiac monitor implanted under the skin proved six to seven times more likely than standard monitoring methods to find an irregular heart rhythm that may have caused a patient's stroke, according to a late-breaking science report presented at the American Stroke Association's International Stroke Conference 2014.

As many as 30 percent of ischemic strokes – those caused by a clot in a blood vessel supplying the brain – have no identifiable cause. But one possible explanation is a type of called atrial fibrillation, or AF. With atrial fibrillation, the heart's upper chambers (atria) beat erratically and rapidly, slowing blood flow in the atria and promoting clot formations there. Stroke risk is about five times higher in people with atrial fibrillation.

"Atrial fibrillation can be difficult to detect due to its sometimes intermittent nature, and the fact that it isn't always accompanied by symptoms," said Richard A. Bernstein, M.D., Ph.D., an author of the new study and professor of neurology at Northwestern University's Feinberg School of Medicine in Chicago. "For a patient who has had an unexplained , it's really important to determine if they have AF, because left untreated, it could result in a second and even more devastating stroke."

The new study, called CRYSTAL-AF (CRYptogenic STroke And UnderLying Atrial Fibrillation), included 441 who had an unexplained stroke. All had at least 24 hours of standard cardiac monitoring within 90 days of the stroke, and half were tracked with an insertable monitor (the Reveal® XT by Medtronic) which can provide data continuously for up to three years.

Six months later, atrial fibrillation had been found in 8.9 percent of patients with an insertable monitor, versus 1.4 percent of those who had standard testing. A year later, the condition had been detected in 12.4 percent of patients with the insertable monitor, compared with 2 percent of the others. After three years, that gap was 30 percent with the insertable monitor, versus 3 percent for standard testing.

The study was conducted in 55 centers in the United States, Canada and Europe. Limitations of the research include variation in methods of standard cardiac monitoring in the control arm, due to different local practices, he said.

Most people who have a stroke caused by a blood clot are given aspirin or similar drugs, such as clopidogrel, to prevent another stroke, said Bernstein, who is also director of the Stroke Program at Northwestern Memorial Hospital. But in patients with atrial fibrillation, anticoagulants, such as warfarin, or the newer anticoagulants, have been found much more effective at preventing stroke. Anticoagulants aren't routinely given in the absence of because they can be riskier and more inconvenient for patients.

"Finding AF after a stroke changes therapy from the aspirin class of drugs, which are not very effective in AF, to anticoagulants," he said. Among patients in the study found to have AF, oral anticoagulants were prescribed for 97 percent of cases, the researchers reported.

An insertable cardiac monitor resembles a USB flash drive and has two electrodes to monitor heart rhythm. It can detect various kinds of heart irregularities and stores a log of events that indicates when and for how long each event occurred, and what was the heart rate.

The device is slipped under the skin of the chest via a small incision, using local anesthetic in a brief outpatient procedure. The monitor does not touch the heart.

The benefits of the insertable device far outweigh risks, Bernstein said, noting just 2.4 percent of the devices had to be removed in the study because of complications, and the patients had no long-term problems. "On the other hand, if a stroke patient has AF that hasn't been caught; they could be at very high risk of another potentially disabling stroke because they aren't on the right medication."

However, the study did not have enough participants to see whether there was a difference between the two groups in rates of subsequent stroke. Stroke guidelines currently call for only 24-hour monitoring. The new study suggests long-term continuous monitoring may uncover more AF in patients with unexplained stroke, and can be useful if traditional monitoring fails.

Explore further: Aspirin still overprescribed for stroke prevention in atrial fibrillation

Related Stories

Aspirin still overprescribed for stroke prevention in atrial fibrillation

January 28, 2014
Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.

Women and African-Americans at higher risk of heart attack from atrial fibrillation

November 4, 2013
Doctors have known for years that atrial fibrillation (AF), or irregular heartbeat, increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart ...

Female gender increases stroke risk in AF patients aged over 75 years by 20%

August 27, 2012
Female gender increases the risk of stroke in patients with atrial fibrillation (AF) aged >75 years by 20%, according to a study presented today at the ESC Congress 2012. The findings were presented by Anders Mikkelsen, from ...

Impact of AF on stroke risk eliminated with multiple risk factors

September 1, 2013
Patients with five or more risk factors have the same stroke risk as patients with atrial fibrillation, according to research presented at the ESC Congress today by Dr. Christine Benn Christiansen from Denmark. The study ...

The Medical Minute: Atrial Fibrillation -- What is It?

October 6, 2011
Atrial fibrillation (AF) is the most common heart rhythm disturbance in the United States and affects 2 to 4 million Americans. It is usually a disease of aging, however it can affect people of all ages -- 1 percent of people ...

Higher risk of stroke from common heart disease

February 11, 2013
(Medical Xpress)—Australians are being warned of a higher risk of stroke caused by the nation's most common heart rhythm disorder, atrial fibrillation.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.